Tumor suppression and potentiation by manipulation of pp32 expression. - Wikidata - wikimedia - TriplyDB

Tumor suppression and potentiation by manipulation of pp32 expression.

Tumor suppression and potentiation by manipulation of pp32 expression.

http://www.wikidata.org/entity/Q33947462

about

Downregulation of ANP32B, a novel substrate of caspase-3, enhances caspase-3 activation and apoptosis induction in myeloid leukemic cells HMG2 interacts with the nucleosome assembly protein SET and is a target of the cytotoxic T-lymphocyte protease granzyme A The role of LANP and ataxin 1 in E4F-mediated transcriptional repression Differential gene expression induced by insulin and insulin-like growth factor-II through the insulin receptor isoform A Cleaving the oxidative repair protein Ape1 enhances cell death mediated by granzyme A Analysis of the adenovirus E1B-55K-anchored proteome reveals its link to ubiquitination machinery.MicroRNA-21 targets tumor suppressor genes ANP32A and SMARCA4 Cpd-1 null mice display a subtle neurological phenotype The crystal structure of the tumor suppressor protein pp32 (Anp32a): Structural insights into Anp32 family of proteins Mapmodulin/leucine-rich acidic nuclear protein binds the light chain of microtubule-associated protein 1B and modulates neuritogenesis pp32 (ANP32A) expression inhibits pancreatic cancer cell growth and induces gemcitabine resistance by disrupting HuR binding to mRNAs A new method to detect loss of heterozygosity using cohort heterozygosity comparisons.Cracking the ANP32 whips: important functions, unequal requirement, and hints at disease implications.pp32 reduction induces differentiation of TSU-Pr1 cells.ANP32B deficiency impairs proliferation and suppresses tumor progression by regulating AKT phosphorylation.Acidic leucine-rich nuclear phosphoprotein-32A (ANP32A) association with lymph node metastasis predicts poor survival in oral squamous cell carcinoma patients.Generation and characterization of LANP/pp32 null mice.HuR's role in gemcitabine efficacy: an exception or opportunity?Reduction of pp32 expression in poorly differentiated pancreatic ductal adenocarcinomas and intraductal papillary mucinous neoplasms with moderate dysplasia.PHAPI/pp32 suppresses tumorigenesis by stimulating apoptosis.Phosphorylated retinoblastoma protein complexes with pp32 and inhibits pp32-mediated apoptosis.A novel monoclonal antibody DC63 reveals that inhibitor 1 of protein phosphatase 2A is preferentially nuclearly localised in human brain.PHAP1 promotes glioma cell proliferation by regulating the Akt/p27/stathmin pathway.Identification of genes promoting angiogenesis in mouse lung by transcriptional profiling.SET complex in serous epithelial ovarian cancer

P2860

Q22001541-08DE5DED-8490-4942-BF18-78EEFEEAFE39 Q24292517-4A7782CA-3CE6-4FED-BAE3-C9AAE3167E10 Q24308036-063EE296-612C-4E42-9DB4-1F338D1E369F Q24311360-BFFE66A2-9E29-4CFA-8341-123B7DF12D58 Q24338600-D46175C9-D567-461C-ACE1-33B1BDFAE7DC Q24538586-20DF3C7B-DC30-4CD5-B663-FE8E2B4D4B93 Q24633718-20289B64-614D-4E72-9088-343026E62AB8 Q27320487-BFCB611B-045B-4DAC-9C12-EF66500729E8 Q27645802-68F6A026-A9C4-4CC2-AF8E-FE3CA1A9F7D6 Q28179296-777CC061-E6DF-476E-8C49-9CCECB88C912 Q28476402-46D9FDC7-9458-4F1D-A3AC-44C29A682B23 Q33576286-7C39E4AC-E27C-4A7F-97AD-98B0526B9636 Q34730329-D41BFDCF-0489-4AD3-BBBA-DE2340683C31 Q35083306-F3DCC68F-06F4-42CB-9D7A-32FA87B3D68D Q36847561-6BB8602B-E6EE-4DB2-B073-DA918B218C1F Q36998120-99C97911-E082-4E8B-A09B-2E86E4BCDAF9 Q37277403-8723A192-9B4A-43F0-843E-1033FF9F7FD3 Q37940426-68EA5A31-5E7F-4E82-9718-445D329B78F5 Q40074127-72EDA819-FB91-42A5-86C0-A71F3B40252F Q42181561-C56C2D71-F8FF-4033-9733-1A43A32EF691 Q45269798-AD3D2496-9CC5-46F8-B581-F00A6B4E61C5 Q48291880-EF540011-F387-4868-8BD8-AB6567ECE7EE Q52581030-3386C87F-34F4-49E8-91CD-2F94FF317842 Q54788103-FE3B9425-648C-453E-AEF1-A2AC322E08FA Q58325223-717246CE-A511-4514-856D-509B96E467DB

P2860

Tumor suppression and potentiation by manipulation of pp32 expression.

http://www.wikidata.org/entity/Q33947462

description

2001 nî lūn-bûn

@nan

2001 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

Tumor suppression and potentiation by manipulation of pp32 expression.

@ast

Tumor suppression and potentiation by manipulation of pp32 expression.

@en

type

label

Tumor suppression and potentiation by manipulation of pp32 expression.

@ast

Tumor suppression and potentiation by manipulation of pp32 expression.

@en

prefLabel

Tumor suppression and potentiation by manipulation of pp32 expression.

@ast

Tumor suppression and potentiation by manipulation of pp32 expression.

@en

P1433

Q33947462-72E18B8C-BF9D-4838-BBAD-CFE71F4C4D71

P1476

Q33947462-511C7380-9AE8-4559-914F-C58AFCADCB57

P2093

Q33947462-293B6356-18A4-41C8-AF18-3D211DD916B1

Q33947462-31B3B31B-8436-4219-B627-80A9440F44F3

Q33947462-3B812DE4-0B73-4A23-8CBB-1CC738293CB7

Q33947462-C83DEA28-6E95-4DCC-B326-A75322BBC2EA

P2860

Q33947462-003B663A-8B38-4E01-9947-FB847D999C50

Q33947462-03D8827B-FAB2-47DB-9F6F-A31E7910A011

Q33947462-0A5E22C4-68C5-4627-BF1A-F1FF5B35AF9C

Q33947462-2D00967C-DC50-49F7-B1E8-549E83D7BEC4

Q33947462-30E3383F-5447-40BA-BD46-3B3253749068

Q33947462-411850B9-343A-4B45-BAF8-64CA65168749

Q33947462-6B8F2047-9FA7-48BE-A5A9-997969C424DE

Q33947462-74E48177-94E1-4188-9AE4-87118DF40168

Q33947462-8A4168CC-8C78-452F-BA81-606CB07654A4

Q33947462-9D67CA08-0177-40DF-A424-78C32A0BB475

P2888

Q33947462-84B38339-2611-4347-BF95-F29D3EEC37AB

P304

Q33947462-E5F75540-74D1-48E8-9531-CC2D72F4B4A2

P31

Q33947462-73D9BBA2-5C3B-4968-80B8-AB9EE01C1AAA

P356

Q33947462-889699AC-5610-4E58-A500-1FE4EB975E5D

P407

Q33947462-31094B2C-2502-4151-895A-15A6E020CB5B

P433

Q33947462-1B9FB910-990B-474B-9340-93B8956B2AD3

P478

Q33947462-028658C7-FF1E-477A-A6FB-6BF218F545A4

P577

Q33947462-7C78BEAB-FA07-41D2-8B65-C5AEAD0F034A

P5875

Q33947462-552BA596-43D3-4B30-B54F-32425D6A43F3

P6179

Q33947462-04812D61-7B5E-40E6-9734-907CC56432F5

P698

Q33947462-7B4282E6-D4F6-46BC-A2E3-EA9DDE15D40C

P356

P1433

P1476

Tumor suppression and potentiation by manipulation of pp32 expression.

@en

P2093

Bai J

http://www.w3.org/2001/XMLSchema#string

Brody JR

http://www.w3.org/2001/XMLSchema#string

Kadkol SS

http://www.w3.org/2001/XMLSchema#string

Pasternack GR

http://www.w3.org/2001/XMLSchema#string

P2860

Glucose catabolism in cancer cells. The type II hexokinase promoter contains functionally active response elements for the tumor suppressor p53

Structure of pp32, an acidic nuclear protein which inhibits oncogene-induced formation of transformed foci

Protein ligands to HuR modulate its interaction with target mRNAs in vivo

Alterations of the PPP2R1B gene in human lung and colon cancer

Regulation of beta-catenin signaling by the B56 subunit of protein phosphatase 2A

Regulation of protein kinase cascades by protein phosphatase 2A.

Modulation of oncogenic potential by alternative gene use in human prostate cancer.

Identification of sequences required for inhibition of oncogene-mediated transformation by pp32.

A U-rich element in the 5' untranslated region is necessary for the translation of p27 mRNA.

Molecular identification of I1PP2A, a novel potent heat-stable inhibitor protein of protein phosphatase 2A.

P2888

P304

2153-2160

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.ONC.1204294

http://www.w3.org/2001/XMLSchema#string

P407

P433

17

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P577

2001-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11978332

http://www.w3.org/2001/XMLSchema#string

P6179

1001572839

http://www.w3.org/2001/XMLSchema#string

P698

11360199

http://www.w3.org/2001/XMLSchema#string